PCMT1 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltrates in Breast Cancer

MLA

Jufang Guo, et al. “PCMT1 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltrates in Breast Cancer.” BioMed Research International, vol. 2022, Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d470d92a2b06cd97e1939bcce60cfa1d&authtype=sso&custid=ns315887.

APA

Jufang Guo, Xuelian Du, & Chaolin Li. (2022). PCMT1 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltrates in Breast Cancer. BioMed Research International, 2022.

Chicago

Jufang Guo, Xuelian Du, and Chaolin Li. 2022. “PCMT1 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltrates in Breast Cancer.” BioMed Research International 2022 (January). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d470d92a2b06cd97e1939bcce60cfa1d&authtype=sso&custid=ns315887.